Bausch Health Companies (BHC) Retained Earnings (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Retained Earnings came in at -$11.1 billion in Q1 2026, down 446.57% year-on-year from $3.2 billion in Q1 2025, and down 14.72% quarter-over-quarter from -$9.7 billion in Q4 2025.
Bausch Health Companies (BHC) Retained Earnings (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Retained Earnings across 18 years of filings, most recently posting -$11.1 billion for Q1 2026.
- Retained Earnings for Q1 2026 came in at -$11.1 billion, down 446.57% year-over-year; the trailing twelve-month figure through Mar 2026 was -$11.1 billion (down 446.57% YoY), and the FY2025 annual result was -$9.7 billion, down 343.64% from the prior year.
- Retained Earnings came in at -$11.1 billion for Q1 2026 at Bausch Health Companies, down from -$9.7 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$1.8 billion in Q2 2025 to a low of -$11.1 billion in Q1 2026.
- The 5-year median for Retained Earnings is -$2.2 billion (2024), against an average of -$5.6 billion.
- Across the five-year window, Retained Earnings jumped 81.85% in 2025 and plunged 446.57% in 2026, its largest moves.
- Bausch Health Companies' Retained Earnings stood at -$2.1 billion in 2022, then gained by 8.51% to -$1.9 billion in 2023, then slipped by 15.84% to -$2.2 billion in 2024, then tumbled by 343.64% to -$9.7 billion in 2025, then retreated by 14.72% to -$11.1 billion in 2026.
- The last three Retained Earnings figures came in at -$11.1 billion (Q1 2026), -$9.7 billion (Q4 2025), and -$1.8 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -1.87 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -4.41 Mn |
| 10 | Bausch Health Companies | 1.91 Bn | 1.58 Bn | 2.48 Bn | -11.09 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.09 Bn |
| Dec 31, 2025 | -9.67 Bn |
| Sep 30, 2025 | -1.80 Bn |
| Jun 30, 2025 | -1.79 Bn |
| Mar 31, 2025 | -2.03 Bn |
| Dec 31, 2024 | -2.18 Bn |
| Sep 30, 2024 | -9.92 Bn |
| Jun 30, 2024 | -9.83 Bn |
| Mar 31, 2024 | -1.92 Bn |
| Dec 31, 2023 | -1.88 Bn |
| Sep 30, 2023 | -2.05 Bn |
| Jun 30, 2023 | -9.36 Bn |
| Mar 31, 2023 | -9.39 Bn |
| Dec 31, 2022 | -2.06 Bn |
| Sep 30, 2022 | -8.78 Bn |
| Jun 30, 2022 | -9.18 Bn |
| Mar 31, 2022 | -1.97 Bn |
| Dec 31, 2021 | -8.96 Bn |
| Sep 30, 2021 | -9.03 Bn |
| Jun 30, 2021 | -9.22 Bn |